Cost-effectiveness of pramipexole compared with piribedil in early Parkinson's disease patients

被引:0
|
作者
Chikina, ES [1 ]
Gusev, EL [1 ]
Belousov, YB [1 ]
Guecht, AB [1 ]
机构
[1] Russian State Med Univ, Moscow 117437, Russia
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:321 / 321
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [2] Cost-effectiveness of pramipexole in Parkinson's disease in the United States
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Holloway, R
    [J]. NEUROLOGY, 1998, 50 (04) : A298 - A299
  • [3] COST-EFFECTIVENESS ANALYSIS OF PRAMIPEXOLE EXTENDED RELEASE MONOTHERAPY IN EARLY PARKINSON'S DISEASE
    Belousov, D.
    Afanasieva, E.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A757 - A757
  • [4] Effects of piribedil and pramipexole in tremor predominant patients with early Parkinson's disease
    Subutay-Oztekin, N.
    Oztekin, M. F.
    Sari-Polat, R.
    Ak, F.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S311 - S311
  • [5] Cost effectiveness of pramipexole in Parkinson's disease in the US
    Hoerger, TJ
    Bala, MV
    Rowland, C
    Greer, M
    Chrischilles, EA
    Holloway, RG
    [J]. PHARMACOECONOMICS, 1998, 14 (05) : 541 - 557
  • [6] Pramipexole and levodopa in early Parkinson's disease - Dynamic changes in cost effectiveness
    Noyes, K
    Dick, AW
    Holloway, RG
    [J]. PHARMACOECONOMICS, 2005, 23 (12) : 1257 - 1270
  • [7] Cost Effectiveness of Pramipexole in Parkinson’s Disease in the US
    Thomas J. Hoerger
    Mohan V. Bala
    Clayton Rowland
    Marianne Greer
    Elizabeth A. Chrischilles
    Robert G. Holloway
    [J]. PharmacoEconomics, 1998, 14 : 541 - 557
  • [8] Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease
    Verschuur, Constant V. M.
    Suwijn, Sven R.
    de Haan, Rob J.
    Boel, Judith A.
    Post, Bart
    Bloem, Bas R.
    van Hilten, Johannes J.
    van Laar, Teus
    Tissingh, Gerrit
    Munts, Alexander
    Dijkgraaf, Marcel G. W.
    de Bie, Rob M. A.
    [J]. JOURNAL OF PARKINSONS DISEASE, 2022, 12 (07) : 2171 - 2178
  • [9] Pramipexole and levodopa in early parkinson’s diseaseDynamic changes in cost effectiveness
    Katia Noyes
    Andrew W. Dick
    Robert G. Holloway
    [J]. PharmacoEconomics, 2005, 23 : 1257 - 1270
  • [10] Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications
    Dams, Judith
    Balzer-Geldsetzer, Monika
    Siebert, Uwe
    Deuschl, Guenther
    Schuepbach, W. M. Michael
    Krack, Paul
    Timmermann, Lars
    Schnitzler, Alfons
    Reese, Jens-Peter
    Dodel, Richard
    [J]. MOVEMENT DISORDERS, 2016, 31 (08) : 1183 - 1191